Details for 2022171033
Up to date per 02.04.2026
Actions
Details for 2022171033
Granted/Registered
European Patent
14.09.2022 A
24.04.2024 B1
24.09.2018
US
201862735670 P
24.09.2018
US
201862735680 P
09.11.2018
US
201862758387 P
05.03.2019
US
201962813888 P
14.03.2019
US
201962818514 P
A61K 31/232 20060101AFI20220729BHEP
Owner
Amarin Pharmaceuticals Ireland Limited88 Harcourt Street Dublin D02 DK18 Dublin2IE
Representative
Representative
BEER & PARTNER PATENTANWÄLTE KGLindengasse 81070 WienAT
Inventor
SONI, Paresh Mystic, 06355US
Information about Fees